Z-0592-2018 Class II Terminated

Recalled by Cepheid — Sunnyvale, CA

FDA device recall Z-0592-2018 was initiated by Cepheid on Oct 9, 2017 and is designated Class II. Reason for recall: Cepheid has received reports that some of our customers have experienced a higher number of temperature drift errors than would typically be expected when using this test and its intended use… The recall status is terminated (terminated Feb 13, 2018). Affected quantity: 3,586 kits (49,400 units).

Recall details

Product Type
Devices
Report Date
Feb 21, 2018
Initiation Date
Oct 9, 2017
Termination Date
Feb 13, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,586 kits (49,400 units)

Product description

Xpert CT/NG Catalog GXCT/NG-120 Batch 1000049568, Catalog GXCT/NG-10 Batch 1000053075, Catalog GXCT/NG-10 Batch 1000056156 and Catalog GXCT/NG-10 Batch 1000056157. Is a qualitative in vitro real-time PCR test.

Reason for recall

Cepheid has received reports that some of our customers have experienced a higher number of temperature drift errors than would typically be expected when using this test and its intended use specimen types. Investigation of the issue also revealed an occasional probability of false negative results which remains consistent with package insert claims.

Distribution pattern

Worldwide Distribution -- USA, Puerto Rico, and Haiti.

Code information

Lot numbers: 25718, 25719, 25725, and 25727.

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0592-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0592-2018. Report a data issue: hello@regdatalab.com.